Similar articles for PMID: 22198713

Year	Number of Results
2002	1
2003	10
2004	21
2005	29
2006	30
2007	24
2008	14
2009	24
2010	20
2011	31
2012	20
2013	29
2014	19
2015	23
2016	14
2017	17
2018	16
2019	9
2020	4
2021	9
2022	8
2023	1
2024	0

1

Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).

Pan Q, Ramakrishnaiah V, Henry S, Fouraschen S, de Ruiter PE, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ. Pan Q, et al. Gut. 2012 Sep;61(9):1330-9. doi: 10.1136/gutjnl-2011-300449. Epub 2011 Dec 23. Gut. 2012. PMID: 22198713

2

Potential applications of siRNA in hepatitis C virus therapy.

Smolic R, Volarevic M, Wu CH, Wu GY. Smolic R, et al. Curr Opin Investig Drugs. 2006 Feb;7(2):142-6. Curr Opin Investig Drugs. 2006. PMID: 16499284 Review.

3

Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.

Sun Y, Li Z, Li L, Li J, Liu X, Li W. Sun Y, et al. Int J Mol Med. 2007 Apr;19(4):705-11. Int J Mol Med. 2007. PMID: 17334648

4

RNA interference targeting Fas protects mice from fulminant hepatitis.

Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J. Song E, et al. Nat Med. 2003 Mar;9(3):347-51. doi: 10.1038/nm828. Epub 2003 Feb 10. Nat Med. 2003. PMID: 12579197

5

Therapeutic application of RNA interference for hepatitis C virus.

Watanabe T, Umehara T, Kohara M. Watanabe T, et al. Adv Drug Deliv Rev. 2007 Oct 10;59(12):1263-76. doi: 10.1016/j.addr.2007.03.022. Epub 2007 Aug 11. Adv Drug Deliv Rev. 2007. PMID: 17822803 Review.

6

Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.

Kim SI, Shin D, Lee H, Ahn BY, Yoon Y, Kim M. Kim SI, et al. J Hepatol. 2009 Mar;50(3):479-88. doi: 10.1016/j.jhep.2008.10.029. Epub 2008 Dec 27. J Hepatol. 2009. PMID: 19155084

7

Potential role of RNAi in the treatment of HCV infection.

Volarevic M, Smolic R, Wu CH, Wu GY. Volarevic M, et al. Expert Rev Anti Infect Ther. 2007 Oct;5(5):823-31. doi: 10.1586/14787210.5.5.823. Expert Rev Anti Infect Ther. 2007. PMID: 17914916 Review.

8

Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.

Zhang J, Yamada O, Sakamoto T, Yoshida H, Iwai T, Matsushita Y, Shimamura H, Araki H, Shimotohno K. Zhang J, et al. Virology. 2004 Mar 1;320(1):135-43. doi: 10.1016/j.virol.2003.11.023. Virology. 2004. PMID: 15003869 Free article.

9

Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.

Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF. Wu Y, et al. Chin Med J (Engl). 2005 Aug 20;118(16):1351-6. Chin Med J (Engl). 2005. PMID: 16157029

10

[Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].

Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL. Zhang PH, et al. Ai Zheng. 2004 Jun;23(6):619-25. Ai Zheng. 2004. PMID: 15191658 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

338 results

Results by year